Trials / Completed
CompletedNCT06025357
Effects of L-citrulline Supplementation on Vascular Function in Metabolic Syndrome
Effects of L-Citrulline Supplementation on Vascular Function During Fasted and Acute Hyperglycemia in Middle-aged and Older Women With Metabolic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Texas Tech University · Academic / Other
- Sex
- Female
- Age
- 45 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The objective of this project is to provide evidence that L-Citrulline (CIT) supplementation can improve vascular function in the fasted and acute hyperglycemia conditions in middle-aged and older women with metabolic syndrome.
Detailed description
Using a double-blind, randomized, placebo-controlled, and parallel design, middle-aged and older women with metabolic syndrome will be randomized into receiving either CIT supplementation (10g/day) or placebo (Microcrystalline Cellulose) for 4 weeks. The first visit will be approximately 1hr and 30 minutes. The 2nd and 3rd visits will each be approximately 2hrs and 30 minutes, separated by 4 weeks in between each visit. During visits 2 and 3, vascular measurements will be assessed in the fasted state and 30, 60, and 90 minutes after acute glucose ingestion (75g).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | L-Citrulline supplementation | 4 weeks of L-Citrulline supplementation (10 grams/day). |
| DIETARY_SUPPLEMENT | Placebo | 4 weeks of microcrystalline Cellulose supplementation. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2024-05-01
- Completion
- 2024-08-01
- First posted
- 2023-09-06
- Last updated
- 2025-05-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06025357. Inclusion in this directory is not an endorsement.